~~<i id='BB85727CD3'><strike id='BB85727CD3'><tt id='BB85727CD3'><pre id='BB85727CD3'></pre></tt></strike></i>~~

Home» leisure time» leisure time

leisure time

author：fashion 2025-09-28 05:46:49 Page View：514

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Elevance, SCAN deals highlight health insurer acquisition scrutiny
Next article： Apple is now the first public company to be valued at $3 trillion

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

Elevance, SCAN deals highlight health insurer acquisition scrutiny

AdobeAdealisneverreallydoneuntilit’sdone.OnTuesday,twodifferentproposedinsuranceplanacquisitionsondi

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

AdobeRingTherapeutics,agenetherapystartuplaunchedbyFlagshipPioneering,haslaidoffjustunder20%ofitssta